Skip to main content

Want a detailed portfolio tracker?

Soligenix (SNGX) P/E (2012 - 2026)

Soligenix (SNGX) P/E from Mar 8, 2012 to Jul 20, 2026. The TTM Soligenix (SNGX) P/E is -0.23. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Soligenix (SNGX)

YearP/EChange
2026-0.23-62.13%
2025-0.60-24.91%
2024-0.80-72.92%
2023-2.94-85.11%
2022-19.76-40.12%
2021-32.99+8.60%
2020-30.38+7.12%
2019-28.36+140.95%
2018-11.77-49.92%
2017-23.50-96.93%
2016-766.45+1898.51%
2015-38.35+30.04%
2014-29.49-6.88%
2013-31.67+97.44%
2012-16.04N/A

Comparison Soligenix (SNGX) P/E with competitors

Soligenix (SNGX) P/E is -0.23.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.75%
NBYStablecoin Development Corp0.00-101.90%
ENLVEnlivex Ltd0.07-133.03%
FGENFibroGen Inc0.24-205.99%
CHRSCoherus Biosciences Inc0.85-474.66%
FBIOFortress Biotech Inc0.95-519.03%
ORMPOramed Pharmaceuticals Inc1.50-763.66%
AGENAgenus Inc3.01-1428.86%
INVAInnoviva Inc3.15-1492.62%
VXRTVaxart Inc3.55-1667.34%
CRMDCorMedix Inc3.63-1702.09%
CVACCureVac N.V.4.45-2062.93%
GLPGGalapagos NV4.86-2245.38%
SRPTSarepta Therapeutics Inc4.88-2255.62%
ABEOAbeona Therapeutics Inc5.39-2478.79%
ABUSArbutus Biopharma Corp5.60-2570.67%
ZVRAZevra Therapeutics Inc5.89-2699.43%
SPROSpero Therapeutics Inc6.23-2850.09%
CGENCompugen Ltd6.31-2887.84%
RIGLRigel Pharmaceuticals6.87-3134.27%
SLXNSilexion Therapeutics Corp7.30-3321.49%
OMEROmeros Corporation9.26-4188.09%
AUPHAurinia Pharmaceuticals Inc9.58-4332.12%
PLXProtalix BioTherapeutics Inc10.89-4908.79%
ACADAcadia Pharmaceuticals Inc11.73-5278.59%
TBPHTheravance Biopharma Inc12.26-5514.21%
ADMAAdma Biologics Inc12.42-5583.09%
HRMYHarmony Biosciences Holdings Inc13.82-6202.15%
SABSSAB Biotherapeutics Inc14.14-6341.68%
NAGENiagen Bioscience Inc14.82-6642.77%
INCYIncyte Corp15.82-7086.27%
REGNRegeneron Pharmaceuticals Inc15.86-7101.33%
PBYIPuma Biotechnology Inc17.32-7745.56%
CPRXCatalyst Pharmaceuticals Inc17.44-7800.13%
EXELExelixis Inc17.54-7843.71%
TGTXTG Therapeutics Inc18.97-8474.25%
MDXGMimedx Group Inc20.55-9174.73%
XOMAXOMA Royalty Corp22.87-10200.33%
ARGXArgen X SE24.30-10828.80%
CTMXCytomX Therapeutics Inc24.82-11059.77%
XOMAOXOMA Royalty Corp25.34-11291.02%
HALOHalozyme Therapeutics Inc25.62-11414.17%
XOMAPXOMA Royalty Corp25.67-11434.65%
VRTXVertex Pharmaceuticals Inc27.99-12461.09%
RPRXRoyalty Pharma plc - Class A28.69-12767.00%
SLNOSoleno Therapeutics Inc29.02-12911.74%
ASNDAscendis Pharma A/S30.09-13384.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-16840.07%
APLSApellis Pharmaceuticals Inc39.02-17329.84%
BMRNBiomarin Pharmaceutical Inc42.21-18738.67%
KRYSKrystal Biotech Inc45.34-20121.44%
ONCBeiGene Ltd69.54-30805.64%
PHARPharming Group N.V.75.03-33227.61%
TECHBio-Techne Corp101.96-45119.81%
VCELVericel Corp109.92-48635.87%
ALNYAlnylam Pharmaceuticals Inc117.96-52187.60%
GMABGenmab140.29-62045.52%
TLXTelix Pharmaceuticals Ltd162.15-71698.73%
CORTCorcept Therapeutics Inc212.86-94087.43%